{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:21:58Z","timestamp":1781112118517,"version":"3.54.1"},"reference-count":61,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific Research, Qassim University, Saudi Arabia","award":["2023-SDG-1-HMSRC-35893"],"award-info":[{"award-number":["2023-SDG-1-HMSRC-35893"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Dual inhibition of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) is a recognized strategy for enhanced anti-inflammatory effects in small molecules, offering potential therapeutic benefits for individuals at risk of dementia, particularly those with neurodegenerative diseases, common cancers, and diabetes type. Alzheimer\u2019s disease (AD) is the most common cause of dementia, and the inhibition of acetylcholinesterase (AChE) is a key approach in treating AD. Meanwhile, Caspase-3 catalyzes early events in apoptosis, contributing to neurodegeneration and subsequently AD. Structure-based virtual screening of US-FDA-approved molecules from the ZINC15 database identified clozapine (CLOZ) as the dual inhibitor of COX-2 and AChE, with significant binding affinity. Further molecular docking of CLOZ in the active site of LOX and Caspase-3 also showed significant binding potential. Further, the results from molecular docking were validated using molecular dynamics simulation (MDS) studies, confirming the results from molecular docking. The results from MDS showed good binding potential and interactions with key residues. The CLOZ was further assessed using lipopolysaccharide (LPS)-challenged rats treated for thirty days at doses of 5 and 10 mg\/kg, p.o. The results demonstrated modulation of COX-2, 5-LOX, AChE, Caspase-3, and MDA in LPS-induced brains. Additionally, the expression level of IL-10 was also measured. Our results showed a significant decrease in the levels of COX-2, 5-LOX, AChE, Caspase-3, and MDA. Our results also showed a significant decrement in the pro-inflammatory markers NF-\u03baB, TNF-\u03b1, and IL-6 and an improvement in the levels of anti-inflammatory markers IL-10 and TGF-\u03b21. Overall, the findings indicate that CLOZ has potential for neuroprotective effects against LPS-treated rats and can be explored.<\/jats:p>","DOI":"10.3390\/molecules30020266","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:40:40Z","timestamp":1736746840000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multipotent Effect of Clozapine on Lipopolysaccharide-Induced Acetylcholinesterase, Cyclooxygenase-2,5-Lipoxygenase, and Caspase-3: In Vivo and Molecular Modeling Studies"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7255-5254","authenticated-orcid":false,"given":"Minhajul","family":"Arfeen","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra Kumar","family":"Dhaked","sequence":"additional","affiliation":[{"name":"Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata, Kolkata 700054, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-8366","authenticated-orcid":false,"given":"Vasudevan","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"ref_1","unstructured":"Alzheimer\u2019s Disease International (2025, January 04). World Alzheimer Report 2024: Global Perspectives on Attitudes Toward Dementia. Available online: https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2024\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2024). 2024 Alzheimer\u2019s Disease Facts and Figures. Alzheimer\u2019s Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-9-127","article-title":"Involvement of 5-Lipoxygenase Activating Protein in the Amyloidotic Phenotype of an Alzheimer\u2019s Disease Mouse Model","volume":"9","author":"Chu","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Joshi, Y.B., and Pratic\u00f2, D. (2015). The 5-Lipoxygenase Pathway: Oxidative and Inflammatory Contributions to the Alzheimer \u2019s Disease Phenotype. Front. Cell. Neurosci., 8.","DOI":"10.3389\/fncel.2014.00436"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","article-title":"Tackling Neuroin Fl Ammation and Cholinergic de Fi Cit in Alzheimer\u2019 s Disease: Multi-Target Inhibitors of Cholinesterases, Cyclooxygenase-2 and 15-Lipoxygenase","volume":"167","author":"Alfadly","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acschemneuro.1c00507","article-title":"Structural Modification, In Vitro, In Vivo, Ex Vivo, and In Silico Exploration of Pyrimidine and Pyrrolidine Cores for Targeting Enzymes Associated with Neuroinflammation and Cholinergic Deficit in Alzheimer\u2019s Disease","volume":"12","author":"Javed","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1021\/acsomega.1c06344","article-title":"Design, Synthesis, and Bioevaluation of Indole Core Containing 2-Arylidine Derivatives of Thiazolopyrimidine as Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A\/B for the Treatment of Alzheimer Disease","volume":"7","author":"Kazmi","year":"2022","journal-title":"ACS Omega"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/D0FO02809F","article-title":"In Vitro Neuroprotective Potential of Terpenes from Industrial Orange Juice By-Products","volume":"12","author":"Bueno","year":"2021","journal-title":"Food Funct."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106587","DOI":"10.1016\/j.prostaglandins.2021.106587","article-title":"Licofelone, a Potent COX\/5-LOX Inhibitor and a Novel Option for Treatment of Neurological Disorders","volume":"157","author":"Razavi","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108857","DOI":"10.1016\/j.steroids.2021.108857","article-title":"Bioactive Stigmastadienone from Isodon Rugosus as Potential Anticholinesterase, \u03b1 -Glucosidase and COX\/LOX Inhibitor: In-Vitro and Molecular Docking Studies","volume":"172","author":"Alqahtani","year":"2021","journal-title":"Steroids"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Fang, L., Shen, S., Liu, Q., Liu, Z., and Zhao, J. (2022). Combination of NSAIDs with Donepezil as Multi-Target Directed Ligands for the Treatment of Alzheimer\u2019s Disease. Bioorg. Med. Chem. Lett., 75.","DOI":"10.1016\/j.bmcl.2022.128976"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22503","DOI":"10.1039\/D2RA04183A","article-title":"Diclofenac Derivatives as Concomitant Inhibitors of Cholinesterase, Monoamine Oxidase, Cyclooxygenase-2 and 5-Lipoxygenase for the Treatment of Alzheimer\u2019s Disease: Synthesis, Pharmacology, Toxicity and Docking Studies","volume":"12","author":"Javed","year":"2022","journal-title":"RSC Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.04.002","article-title":"Modulation of LOX and COX Pathways via Inhibition of Amyloidogenesis Contributes to Mitoprotection against \u03b2-Amyloid Oligomer-Induced Toxicity in an Animal Model of Alzheimer\u2019s Disease in Rats","volume":"146\u2013147","author":"Kalra","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","article-title":"Design, Synthesis and Evaluation of Novel Feruloyl-Donepezil Hybrids as Potential Multitarget Drugs for the Treatment of Alzheimer\u2019s Disease","volume":"130","author":"Dias","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","article-title":"Multi-Target Design Strategies for the Improved Treatment of Alzheimer\u2019s Disease","volume":"176","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/acs.jmedchem.7b00475","article-title":"Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer\u2019s and Other Neurodegenerative Diseases","volume":"60","author":"Cornec","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Paquot, A., Deprez, B., and Beghyn, T. (2024). Drug repurposing and phenotypic screening: Innovative strategies for treating ultra-rare disorders. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1489094"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Casertano, M., Genovese, M., Paoli, P., Santi, A., Aiello, A., Menna, M., and Imperatore, C. (2022). Insights into Cytotoxic Behavior of Lepadins and Structure Elucidation of the New Alkaloid Lepadin L from the Mediterranean Ascidian Clavelina lepadiformis. Mar. Drugs, 20.","DOI":"10.3390\/md20010065"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the Single to the Multitarget Paradigm in Drug Discovery","volume":"18","author":"Giulianotti","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kukol, A. (2008). Molecular Docking. Molecular Modeling of Proteins, Humana Press.","DOI":"10.1007\/978-1-59745-177-2"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12539-019-00327-w","article-title":"An Overview of Scoring Functions Used for Protein\u2013Ligand Interactions in Molecular Docking","volume":"11","author":"Li","year":"2019","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mani, V., Arfeen, M., Dhaked, D.K., Mohammed, H.A., Amirthalingam, P., and Elsisi, H.A. (2023). Neuroprotective Effect of Methanolic Ajwa Seed Extract on Lipopolysaccharide-Induced Memory Dysfunction and Neuroinflammation: In Vivo, Molecular Docking and Dynamics Studies. Plants, 12.","DOI":"10.3390\/plants12040934"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mani, V., Arfeen, M., Rabbani, S.I., Shariq, A., and Amirthalingam, P. (2022). Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study. Molecules, 27.","DOI":"10.3390\/molecules27217364"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Arfeen, M., Srivastava, A., Srivastava, N., Khan, R.A., Almahmoud, S.A., and Mohammed, H.A. (2024). Design, Classification, and Adverse Effects of NSAIDs: A Review on Recent Advancements. Bioorg. Med. Chem., 112.","DOI":"10.1016\/j.bmc.2024.117899"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s11064-020-03090-3","article-title":"Phosphorylation of 5-LOX: The Potential Set-Point of Inflammation","volume":"45","author":"He","year":"2020","journal-title":"Neurochem. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, K., Cao, F., Gao, N., and Li, W. (2024). Interactions between Inhibitors and 5-Lipoxygenase: Insights from Gaussian Accelerated Molecular Dynamics and Markov State Models. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158295"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2199166","DOI":"10.1080\/14756366.2023.2199166","article-title":"Triple Targeting of Mutant EGFRL858R\/T790M, COX-2, and 15-LOX: Design and Synthesis of Novel Quinazolinone Tethered Phenyl Urea Derivatives for Anti-Inflammatory and Anticancer Evaluation","volume":"38","author":"Kothayer","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Alzarea, S.I., Elmaidomy, A.H., Saber, H., Musa, A., Al-Sanea, M.M., Mostafa, E.M., Hendawy, O.M., Youssif, K.A., Alanazi, A.S., and Alharbi, M. (2021). Potential Anticancer Lipoxygenase Inhibitors from the Red Sea-Derived Brown Algae Sargassum Cinereum: An In-Silico-Supported In-Vitro Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10040416"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1021\/jm0100537","article-title":"Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7","volume":"44","author":"Lee","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Shah, M., Parmar, R., Patel, K., and Nagani, A. (2024). Indole-Based COX-2 Inhibitors: A Decade of Advances in Inflammation, Cancer, and Alzheimer\u2019s Therapy. Bioorg. Chem., 153.","DOI":"10.1016\/j.bioorg.2024.107931"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101729","DOI":"10.1016\/j.jsps.2023.101729","article-title":"Exploring the Role of COX-2 in Alzheimer\u2019s Disease: Potential Therapeutic Implications of COX-2 Inhibitors","volume":"31","author":"Moussa","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1039\/D4RA00766B","article-title":"Exploitation of the Multitarget Role of New Ferulic and Gallic Acid Derivatives in Oxidative Stress-Related Alzheimer\u2019s Disease Therapies: Design, Synthesis and Bioevaluation","volume":"14","author":"Hussain","year":"2024","journal-title":"RSC Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-130506","article-title":"Involvement of 5-Lipoxygenase in Alzheimer\u2019s Disease: A Role for DNA Methylation","volume":"37","author":"Arosio","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejps.2018.06.003","article-title":"Safer Anti-Inflammatory Therapy through Dual COX-2\/5-LOX Inhibitors: A Structure-Based Approach","volume":"121","author":"Jacob","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4103\/1673-5374.211185","article-title":"Evidence for Using a Dual COX 1\/2 and 5-LOX Inhibitor in Neurodegenerative Diseases","volume":"12","author":"Irrera","year":"2017","journal-title":"Neural Regen. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-3-12","article-title":"Inhibition of NF-\u039aB Activation by 5-Lipoxygenase Inhibitors Protects Brain against Injury in a Rat Model of Focal Cerebral Ischemia","volume":"3","author":"Jatana","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11064-021-03227-y","article-title":"Interaction of NF-\u039aB and Wnt\/\u03b2-Catenin Signaling Pathways in Alzheimer\u2019s Disease and Potential Active Drug Treatments","volume":"46","author":"Liu","year":"2021","journal-title":"Neurochem. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-013-0633-0","article-title":"TNF-\u03b1 Signalling and Inflammation: Interactions between Old Acquaintances","volume":"62","year":"2013","journal-title":"Inflamm. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1007\/s00018-021-03900-z","article-title":"TRIMs: Selective Recruitment at Different Steps of the NF-\u039aB Pathway\u2014Determinant of Activation or Resolution of Inflammation","volume":"78","author":"Roy","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s43440-021-00258-8","article-title":"Mechanistic Insight on the Role of Leukotriene Receptors in Ischemic\u2013Reperfusion Injury","volume":"73","author":"Khan","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wautier, J.L., and Wautier, M.P. (2023). Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans: A Mini Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119647"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J.M., and Inestrosa, N.C. (2022). Inflammation Context in Alzheimer\u2019s Disease, a Relationship Intricate to Define. Biol. Res., 55.","DOI":"10.1186\/s40659-022-00404-3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","article-title":"The Nuclear Factor-\u039aB\u2013Interleukin-6 Signalling Pathway Mediating Vascular Inflammation","volume":"86","author":"Brasier","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The Role of Interleukin-6 Signaling in Nervous Tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood.V80.4.1004.1004","article-title":"Leukotriene B4 Enhances Interleukin-6 (IL-6) Production and IL-6 Messenger RNA Accumulation in Human Monocytes In Vitro: Transcriptional and Posttranscriptional Mechanisms","volume":"80","author":"Stankova","year":"1992","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the Immune Response in the Brain: IL-10 and Its Regulation","volume":"13","author":"Carriche","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12974-016-0503-0","article-title":"TGF-Beta1 Regulates Human Brain Pericyte Inflammatory Processes Involved in Neurovasculature Function","volume":"13","author":"Rustenhoven","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tins.2012.06.004","article-title":"Caspase-3 in the Central Nervous System: Beyond Apoptosis","volume":"35","author":"Sheng","year":"2012","journal-title":"Trends Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhang, H., Li, N., Li, Z., Li, Y., Yu, Y., and Zhang, L. (2022). The Involvement of Caspases in Neuroinflammation and Neuronal Apoptosis in Chronic Pain and Potential Therapeutic Targets. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.898574"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0891-5849(01)00591-3","article-title":"Oxidative Damage to Mitochondria Is a Preliminary Step to Caspase-3 Activation in Fluoride-Induced Apoptosis in HL-60 Cells","volume":"31","author":"Anuradha","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1096\/fj.03-1038fje","article-title":"Mitochondrial Na+ Overload Is Caused by Oxidative Stress and Leads to Activation of the Caspase 3-Dependent Apoptotic Machinery","volume":"18","author":"Yang","year":"2004","journal-title":"FASEB J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40520-019-01359-4","article-title":"Acetylcholinesterase Inhibitors Targeting the Cholinergic Anti-Inflammatory Pathway: A New Therapeutic Perspective in Aging-Related Disorders","volume":"33","author":"Benfante","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-132738","article-title":"Apoptosis and Oxidative Stress in Neurodegenerative Diseases","volume":"42","author":"Radi","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Teleanu, D.M., Niculescu, A.-G., Lungu, I.I., Radu, C.I., Vlad\u00e2cenco, O., Roza, E., Cost\u0103chescu, B., Grumezescu, A.M., and Teleanu, R.I. (2022). An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115938"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Olufunmilayo, E.O., Gerke-Duncan, M.B., and Holsinger, R.M.D. (2023). Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants, 12.","DOI":"10.3390\/antiox12020517"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainresbull.2010.11.014","article-title":"The Influence of N-Desmethylclozapine and Clozapine on Recognition Memory and BDNF Expression in Hippocampus","volume":"84","author":"Vural","year":"2011","journal-title":"Brain Res. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2019030362","article-title":"Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia","volume":"39","author":"Andrabi","year":"2020","journal-title":"J. Environ. Pathol. Toxicol. Oncol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:26:49Z","timestamp":1759919209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["molecules30020266"],"URL":"https:\/\/doi.org\/10.3390\/molecules30020266","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}